AngioDynamics (ANGO) Misses Q3 EPS by 2c, Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.37 -0.16%
EPS Growth %: -200.0%
Financial Fact:
Total operating expenses: 41.46M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -200.0%
Financial Fact:
Total operating expenses: 41.46M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of ($0.03), $0.02 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $83.2 million.
GUIDANCE:
AngioDynamics sees FY2023 EPS of ($0.06)-($0.01), versus the consensus of ($0.01). AngioDynamics sees FY2023 revenue of $338-342 million, versus the consensus of $342 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Cerebras Systems posts 94% revenue jump, announces OpenAI deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
